SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387308-14-000135
Filing Date
2014-11-14
Accepted
2014-11-13 20:26:05
Documents
15
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q093014.htm 10-Q 325610
2 EX 3.1 articlesofincorporation.htm EX-3.1 853
3 EX 3.1 articlesofincorporation.pdf EX-3.1 494387
4 EX 3.2 bylaws.htm EX-3.2 819
5 EX 3.2 bylaws.pdf EX-3.2 197929
6 EX 3.3 certificateofamendment.htm EX-3.3 945
7 EX 3.3 certificateofamendment.pdf EX-3.3 11101726
8 EX 31.1 ex311.htm EX-31.1 9835
9 EX 32.1 ex321.htm EX-32.1 5716
  Complete submission text file 0001387308-14-000135.txt   17748293

Data Files

Seq Description Document Type Size
10 EX 101.INS axim-20140930.xml EX-101.INS 91195
11 EX 101.SCH axim-20140930.xsd EX-101.SCH 28284
12 EX 101.CAL axim-20140930_cal.xml EX-101.CAL 13214
13 EX 101.DEF axim-20140930_def.xml EX-101.DEF 16810
14 EX 101.LAB axim-20140930_lab.xml EX-101.LAB 127061
15 EX 101.PRE axim-20140930_pre.xml EX-101.PRE 82808
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 141220077
SIC: 4953 Refuse Systems